MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.humpath.2012.11.007

Медицинская библиотека · Human pathology · 2013

Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.

Cho Hanbyoul, Kim Jane Seon-Young, Chung Hyunsoo, Perry Candice, Lee Heejeong, Kim Jae-Hoon

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The tumor suppressor gene ARID1A encodes BAF250a, a component of human SWI/SNF chromatin-remodeling complexes. Loss of BAF250a expression has recently been reported in several tumor types. To investigate the potential correlation between BAF250a and various clinicopathologic parameters, we assessed the expression of BAF250a in archival tumor tissue specimens from 147 patients with cervical cancer and 191 with cervical intraepithelial neoplasia as well as 376 matched nonadjacent normal tissues by immunohistochemical staining. Messenger RNA expression level for BAF250a was decreased in cervical cancer cell lines (P = .013) and tissues (P = .010), when compared with normal cervical epithelial tissue using SYBR Green real-time polymerase chain reaction. BAF250a was also detected in nuclear fractions of HeLa cells and in nuclei of cervical cancer tissue samples by Western blotting and immunohistochemistry, respectively. BAF250a expression gradually decreased in transitioning from normal to cervical carcinoma (P < .001), and this loss of expression was significantly associated with tumor stage (P = .005), tumor grade (P = .029), tumor size (P = .003), and lymph node metastasis (P = .020). In multivariate analysis, overall survival in cervical cancer was significantly reduced in cases with BAF250a loss (hazard ratio, 2.78 [1.01-7.63]; P = .047). Our findings suggest a potential role for BAF250a in providing valuable prognostic information to clinicians for risk assessment in cervical cancer.

Для цитирования: Cho Hanbyoul, Kim Jane Seon-Young, Chung Hyunsoo, Perry Candice, Lee Heejeong, Kim Jae-Hoon. Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.. Human pathology. 2013. DOI: 10.1016/j.humpath.2012.11.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.